Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 49

    1.

    Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.

    Junyent M, Gilabert R, Jarauta E, Núñez I, Cofán M, Civeira F, Pocoví M, Mallén M, Zambón D, Almagro F, Vega J, Tejedor D, Ros E.

    Atherosclerosis. 2009 Aug 8. [Epub ahead of print]PMID: 19717150 [PubMed - as supplied by publisher]Related articles

    2.

    Transcriptional control of human steroid sulfatase.

    Nardi A, Pomari E, Zambon D, Belvedere P, Colombo L, Dalla Valle L.

    J Steroid Biochem Mol Biol. 2009 May;115(1-2):68-74. Epub 2009 Mar 9.PMID: 19429462 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Femoral ultrasound in the assessment of preclinical atherosclerosis. Distribution of intima-media thickness and frequency of atheroma plaques in a Spanish community cohort]

    Junyent M, Gilabert R, Núñez I, Corbella E, Cofána M, Zambón D, Ros E.

    Med Clin (Barc). 2008 Nov 1;131(15):566-71. Spanish. PMID: 19080837 [PubMed - indexed for MEDLINE]Related articles

    4.

    Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.

    Civeira F, Jarauta E, Cenarro A, García-Otín AL, Tejedor D, Zambón D, Mallen M, Ros E, Pocoví M.

    J Am Coll Cardiol. 2008 Nov 4;52(19):1546-53.PMID: 19007590 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.

    Civeira F, Ros E, Jarauta E, Plana N, Zambon D, Puzo J, Martinez de Esteban JP, Ferrando J, Zabala S, Almagro F, Gimeno JA, Masana L, Pocovi M.

    Am J Cardiol. 2008 Nov 1;102(9):1187-93, 1193.e1. Epub 2008 Aug 27.PMID: 18940289 [PubMed - indexed for MEDLINE]Related articles

    6.

    Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment.

    Llaverias G, Pou J, Ros E, Zambón D, Cofán M, Sánchez A, Vázquez-Carrera M, Sánchez RM, Laguna JC, Alegret M.

    Pharmacogenomics. 2008 Aug;9(8):1035-54.PMID: 18681780 [PubMed - indexed for MEDLINE]Related articles

    7.

    Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect.

    Junyent M, Gilabert R, Zambón D, Pocoví M, Mallén M, Cofán M, Núñez I, Civeira F, Tejedor D, Ros E.

    Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):580-6. Epub 2007 Dec 20.PMID: 18096825 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia.

    Meriño-Ibarra E, Puzo J, Jarauta E, Cenarro A, Recalde D, García-Otín AL, Ros E, Martorell E, Pintó X, Franco M, Zambón D, Brea A, Pocoví M, Civeira F.

    J Inherit Metab Dis. 2007 Nov;30(6):970-7. Epub 2007 Oct 20.PMID: 17955342 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of carotid atherosclerosis as assessed by B-mode ultrasonography on the evolution of kidney transplantation.

    Cofan F, Arias M, Nuñez I, Cofan M, Corbella E, Rosich E, Zambón D, Ros E, Gilabert R, Oppenheimer F, Campistol JM.

    Transplant Proc. 2007 Sep;39(7):2236-8.PMID: 17889149 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of apolipoprotein E polymorphism on renal transplantation.

    Cofán F, Cofan M, Rosich E, Campos B, Casals E, Zambon D, Ros E, Oppenheimer F, Campistol JM.

    Transplant Proc. 2007 Sep;39(7):2217-8.PMID: 17889142 [PubMed - indexed for MEDLINE]Related articles

    11.

    Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio.

    Junyent M, Zambón D, Gilabert R, Cofán M, Núñez I, Ros E.

    Atherosclerosis. 2008 Apr;197(2):740-6. Epub 2007 Aug 14.PMID: 17698072 [PubMed - indexed for MEDLINE]Related articles

    12.

    Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham Risk Score.

    Junyent M, Zambón D, Gilabert R, Núñez I, Cofán M, Ros E.

    Atherosclerosis. 2008 Feb;196(2):803-9. Epub 2007 Feb 21.PMID: 17320091 [PubMed - indexed for MEDLINE]Related articles

    13.

    Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia.

    Junyent M, Cofán M, Núñez I, Gilabert R, Zambón D, Ros E.

    Arterioscler Thromb Vasc Biol. 2006 May;26(5):1107-13. Epub 2006 Mar 23.PMID: 16556855 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    [Carotid ultrasound in the assessment of preclinical atherosclerosis. Distribution of intima-media thickness values and plaque frequency in a Spanish community cohort]

    Junyent M, Gilabert R, Núñez I, Corbella E, Vela M, Zambón D, Ros E.

    Med Clin (Barc). 2005 Dec 3;125(20):770-4. Spanish. PMID: 16373026 [PubMed - indexed for MEDLINE]Related articles

    15.

    The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias.

    Junyent M, Gilabert R, Zambón D, Núñez I, Vela M, Civeira F, Pocoví M, Ros E.

    Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2203-8. Epub 2005 Aug 25.PMID: 16123315 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.

    Jiménez S, García-Criado MA, Tàssies D, Reverter JC, Cervera R, Gilabert MR, Zambón D, Ros E, Bru C, Font J.

    Rheumatology (Oxford). 2005 Jun;44(6):756-61. Epub 2005 Mar 9.PMID: 15757967 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Hypertriglyceridemic acute pancreatitis. Is its clinical course different from lithiasic acute pancreatitis?]

    Navarro S, Cubiella J, Feu F, Zambón D, Fernández-Cruz L, Ros E.

    Med Clin (Barc). 2004 Oct 30;123(15):567-70. Spanish. PMID: 15535937 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.

    Roglans N, Vázquez-Carrera M, Alegret M, Novell F, Zambón D, Ros E, Laguna JC, Sánchez RM.

    Eur J Clin Pharmacol. 2004 Feb;59(12):855-61. Epub 2003 Dec 18.PMID: 14685799 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of apolipoprotein polymorphisms in renal transplant recipients.

    Cofan M, Cofan F, Campos B, Casals E, Zambon D, Ros E, Campistol JM, Oppenheimer F.

    Transplant Proc. 2003 Aug;35(5):1725-6.PMID: 12962772 [PubMed - indexed for MEDLINE]Related articles

    20.

    Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology.

    Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM.

    Neurology. 2003 Jul 22;61(2):199-205.PMID: 12874399 [PubMed - indexed for MEDLINE]Related articles

    21.

    Reductions in plasma cholesterol levels after fenofibrate treatment are negatively correlated with resistin expression in human adipose tissue.

    Jové M, Planavila A, Cabrero A, Novell F, Ros E, Zambón D, Laguna JC, Carrera MV.

    Metabolism. 2003 Mar;52(3):351-5.PMID: 12647275 [PubMed - indexed for MEDLINE]Related articles

    22.

    Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.

    Roglans N, Bellido A, Rodríguez C, Cabrero A, Novell F, Ros E, Zambón D, Laguna JC.

    Clin Pharmacol Ther. 2002 Dec;72(6):692-701.PMID: 12496750 [PubMed - indexed for MEDLINE]Related articles

    23.

    Correlation between Apolipoprotein-E polymorphism and Alzheimer's disease pathology.

    Cruz-Sánchez FF, Durany N, Thome J, Riederer P, Zambón D.

    J Alzheimers Dis. 2000 Nov;2(3-4):223-9.PMID: 12214086 [PubMed]Related articles

    24.

    Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia.

    Gómez-Gerique JA, Ros E, Oliván J, Mostaza JM, Vilardell M, Pintó X, Civeira F, Hernández A, da Silva PM, Rodriguez-Botaro A, Zambón D, Lima J, Díaz C, Aristegui R, Sol JM, Chaves J, Hernández G; ATOMIX Investigators.

    Atherosclerosis. 2002 Jun;162(2):245-51.PMID: 11996943 [PubMed - indexed for MEDLINE]Related articles

    25.

    Influence of renal posttransplantation dyslipidemia on the degree and severity of carotid and femoral atherosclerosis evaluated by B-mode ultrasound.

    Cofan F, Gilabert R, Nunez I, Zambon D, Ros E, Casals E, Cofan M, Muray S, Campistol JM, Bru C, Oppenheimer F.

    Transplant Proc. 2002 Feb;34(1):412-4. No abstract available. PMID: 11959349 [PubMed - indexed for MEDLINE]Related articles

    26.

    Pravastatin improves low-density lipoprotein oxidation in renal transplantation.

    Cofan F, Zambon D, Laguna JC, Casals E, Ros E, Cofan M, Campistol JM, Oppenheimer F.

    Transplant Proc. 2002 Feb;34(1):389-91. No abstract available. PMID: 11959339 [PubMed - indexed for MEDLINE]Related articles

    27.

    Effect of pravastatin treatment on the evolution of extracoronary atherosclerosis in renal transplant patients.

    Cofan F, Gilabert R, Zambon D, Nunez I, Ros E, Cofan M, Campistol JM, Bru C, Oppenheimer F.

    Transplant Proc. 2002 Feb;34(1):384-8. No abstract available. PMID: 11959338 [PubMed - indexed for MEDLINE]Related articles

    28.

    Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus.

    Cofan F, Zambon D, Laguna JC, Ros E, Casals E, Cofan M, Campistol JM, Oppenheimer F.

    Transplant Proc. 2002 Feb;34(1):377-8. No abstract available. PMID: 11959335 [PubMed - indexed for MEDLINE]Related articles

    29.

    Fatty acid composition of low-density lipoprotein in renal transplant recipients treated with cyclosporine.

    Cofan F, Zambon D, Laguna JC, Ros E, Casals E, Cofan M, Campistol JM, Oppenheimer F.

    Transplant Proc. 2002 Feb;34(1):374-6. No abstract available. PMID: 11959334 [PubMed - indexed for MEDLINE]Related articles

    30.

    Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cells.

    Muñoz S, Merlos M, Zambón D, Rodríguez C, Sabaté J, Ros E, Laguna JC.

    J Lipid Res. 2001 Dec;42(12):2069-76.PMID: 11734580 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Increased prevalence of carotid and femoral atherosclerosis in renal transplant recipients.

    Cofan F, Nuñez I, Gilabert R, Zambon D, Ros E, Cofan M, Muray S, Mansilla E, Bru C, Oppenheimer F.

    Transplant Proc. 2001 Feb-Mar;33(1-2):1254-6. No abstract available. PMID: 11267281 [PubMed - indexed for MEDLINE]Related articles

    32.

    High-monounsaturated fat, olive oil-rich diet has effects similar to a high-carbohydrate diet on fasting and postprandial state and metabolic profiles of patients with type 2 diabetes.

    Rodríguez-Villar C, Manzanares JM, Casals E, Pérez-Heras A, Zambón D, Gomis R, Ros E.

    Metabolism. 2000 Dec;49(12):1511-7.PMID: 11145109 [PubMed - indexed for MEDLINE]Related articles

    33.

    Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial.

    Zambón D, Sabaté J, Muñoz S, Campero B, Casals E, Merlos M, Laguna JC, Ros E.

    Ann Intern Med. 2000 Apr 4;132(7):538-46. Erratum in: Ann Intern Med 2000 Oct 17;133(8):659. PMID: 10744590 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Oxidation of low-density lipoproteins in renal transplant recipients.

    Cofan F, Zambon D, Rodriguez C, Laguna JC, Vazquez M, Casals E, Torregrosa J, Ros E, Oppenheimer F.

    Transplant Proc. 1999 Sep;31(6):2333-4. No abstract available. PMID: 10500604 [PubMed - indexed for MEDLINE]Related articles

    35.

    Fatty acid composition in low-density lipoproteins from renal transplant recipients.

    Cofan F, Zambon D, Rodriguez C, Laguna JC, Vazquez M, Casals E, Torregrosa J, Ros E, Oppenheimer F.

    Transplant Proc. 1999 Sep;31(6):2330-2. No abstract available. PMID: 10500603 [PubMed - indexed for MEDLINE]Related articles

    36.

    Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance.

    Musso P, Cox I, Vidano E, Zambon D, Panteghini M.

    Clin Biochem. 1999 Mar;32(2):125-30.PMID: 10211629 [PubMed - indexed for MEDLINE]Related articles

    37.

    Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.

    Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.

    Metabolism. 1999 Jan;48(1):47-54.PMID: 9920144 [PubMed - indexed for MEDLINE]Related articles

    38.

    Benzene in environmental air and human blood.

    Brugnone F, Perbellini L, Romeo L, Bianchin M, Tonello A, Pianalto G, Zambon D, Zanon G.

    Int Arch Occup Environ Health. 1998 Nov;71(8):554-9.PMID: 9860165 [PubMed - indexed for MEDLINE]Related articles

    39.

    Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia.

    Sanllehy C, Casals E, Rodriguez-Villar C, Zambón D, Ojuel J, Ballesta AM, Ros E.

    Metabolism. 1998 May;47(5):560-5.PMID: 9591747 [PubMed - indexed for MEDLINE]Related articles

    40.

    Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.

    Vázquez M, Zambón D, Hernández Y, Adzet T, Merlos M, Ros E, Laguna JC.

    Br J Clin Pharmacol. 1998 Mar;45(3):265-9.PMID: 9517370 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Apolipoprotein E polymorphism and gallstones.

    Bertomeu A, Ros E, Zambón D, Vela M, Pérez-Ayuso RM, Targarona E, Trías M, Sanllehy C, Casals E, Ribó JM.

    Gastroenterology. 1996 Dec;111(6):1603-10.PMID: 8942740 [PubMed - indexed for MEDLINE]Related articles

    42.

    [Carotid atherosclerosis evaluated by two-dimensional ultrasonography in patients with primary hypercholesterolemia]

    Zambón D, Gilabert R, Ros E, Casals E, Sanllehy C, Rodríguez C, Bru C.

    Med Clin (Barc). 1995 Dec 8;105(20):761-7. Spanish. PMID: 8558975 [PubMed - indexed for MEDLINE]Related articles

    45.

    [Screening for hypercholesterolemia]

    Ros E, Zambón D, Tresserras R, Brotons C, Castell C.

    Med Clin (Barc). 1994;102 Suppl 1:68-74. Review. Russian. No abstract available. PMID: 8170252 [PubMed - indexed for MEDLINE]Related articles

    46.

    Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.

    Ros E, Zambón D, Bertomeu A, Cusó E, Sanllehy C, Casals E.

    Arch Intern Med. 1991 Feb;151(2):301-5.PMID: 1992957 [PubMed - indexed for MEDLINE]Related articles

    47.

    [Excessive intake of fats and cholesterol in hypercholesterolemic individuals. Effects of dietary intervention on plasma lipids and lipoprotein cholesterol]

    Ros E, Zambón D, Cusó E.

    Med Clin (Barc). 1989 Jan 21;92(2):41-6. Spanish. PMID: 2709886 [PubMed - indexed for MEDLINE]Related articles

    48.
    49.

    Chronic hepatitis: a possible etiology of fatty liver.

    Bruguera M, Zambón D, Ros E, Sánchez Tápias JM, Rodés J.

    Liver. 1985 Jun;5(3):111-6.PMID: 4046749 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...